Shapiro, S. B., Yin, H. ., H. Y. Yu, O. ., Rej, S. ., Suissa, S. ., & Azoulay, L. . (2025). Glucagon-like peptide-1 receptor agonists and risk of suicidality among patients with type 2 diabetes: active comparator, new user cohort study. Bmj, 388, e080679. http://doi.org/10.1136/bmj-2024-080679
*Hypoglycemic Agents/therapeutic use/adverse effects
Simms-Williams, N. ., Treves, N. ., Yin, H. ., Lu, S. ., Yu, O. ., Pradhan, R. ., … Azoulay, L. . (2024). Effect of combination treatment with glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors on incidence of cardiovascular and serious renal events: population based cohort study. Bmj, 385, e078242. http://doi.org/10.1136/bmj-2023-078242